Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors

  • Authors:
    • Quan Jiang
    • Yuan Zhang
    • Jian Chen
    • Yun‑Xiao Zhang
    • Zhu He
  • View Affiliations / Copyright

    Affiliations: Department of Ultrasound, Pudong New Area People's Hospital, Shanghai 201200, P.R. China
  • Pages: 1059-1064
    |
    Published online on: August 4, 2014
       https://doi.org/10.3892/etm.2014.1875
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to investigate the diagnostic value of the Virtual Touch™ tissue quantification (VTQ) and elastosonography technologies in benign and malignant breast tumors. Routine preoperative ultrasound, elastosonography and VTQ examinations were performed on 86 patients with breast lesions. The elastosonography score and VTQ speed grouping of each lesion were measured and compared with the pathological findings. The difference in the elastosonography score between the benign and malignant breast tumors was statistically significant (P<0.05). The detection rate for an elastosonography score of 1‑3 points in benign tumors was 68.09% and that for an elastosonography score of 4‑5 points in malignant tumors was 82.05%. The difference in VTQ speed values between the benign and malignant tumors was also statistically significant (P<0.05). In addition, the diagnostic accuracy of conventional ultrasound, elastosonography, VTQ technology and the combined methods showed statistically significant differences (P<0.05). The use of the three technologies in combination significantly improved the diagnostic accuracy to 91.86%. In conclusion, the combination of conventional ultrasound, elastosonography and VTQ technology can significantly improve accuracy in the diagnosis of breast cancer.

Introduction

The hardness of breast lesions is closely associated with the degree of malignancy, and is the basis for the evaluation of benign or malignant tumors by elastosonography. Elastosonography reflects the hardness of lesions by detecting the differences in hardness between various structures. Conventional elastography can be used to estimate breast tissue elasticity (1) but there are certain disadvantages with freehand compression: the elasticity map obtained is highly dependent on the compressibility limits under stress of the organ and on the extent of the tissue compression applied.

The diagnosis of breast lesions with elastosonography using a 5-point scoring system is relatively subjective (2), as the information displayed relates to a local strain estimated at a given location in the tissues, but this depends on the mechanical properties of the surrounding tissues and it is not quantitative. It has been shown that objective quantification of tissue elasticity could now be possible using acoustic radiation force impulse (ARFI) elastometry. With this system, instead of using external compression, commercially available ultrasound scanners are used to generate short-duration acoustic radiation forces that impart small (1–10 mm) localized displacements in the tissue. The response of the tissue to the radiation force is detected using conventional B-mode imaging pulses in order to track the displacement of tissue which correlates with the local stiffness of the tissue. As a result, two-dimensional images of tissue displacement are generated by the repetition of this process along multiple image lines (3,4). The generated waves can provide a qualitative response (gray-scale map) by virtual touch tissue imaging or a quantitative response (shear wave velocity values, measured in m/s) by virtual touch tissue quantification (VTQ), dependent upon the interactions with the transducer (5). ARFI has been evaluated in various tissues using both the grey-scale map and the shear wave speed (6).

In this study, 86 patients with breast lesions received routine ultrasound, elastosonography and VTQ examinations. The aim of the present study is to investigate the diagnostic value of elastosonography and VTQ technologies in the development of benign or malignant breast tumors.

Materials and methods

General information

Between July 2011 and March 2012, 86 females who had undergone surgical resections of breast lesions in Pudong New Area People’s Hospital (Shanghai, China) were selected for the study. The age of the patients was 18–72 years with a mean of 36.8±13.6 years. The lesion diameters ranged between 7 and 32 mm with an average of 16±8 mm. All lesions were confirmed by histopathology. This study was approved by the Ethics committee of Pudong New Area People’s Hospital (Shanghai, China) and patient informed consent was obtained prior to the study.

Instruments and methods

The Acuson S2000™ Ultrasound System with color Doppler imaging (Siemens Healthcare, Erlangen, Germany) was used for the elastosonography and VTQ technologies. A 9L4 linear array probe was used with a frequency of 9 MHz. A routine ultrasound examination was initially performed to observe the gray-scale sonographic characteristics of the lesions, including shape, size, edge, border, internal and posterior echo, and color Doppler flow characteristics. The elastosonography function was then started to determine the region of interest (ROI). The sampling frame used was ideally greater than the scope of the lesion and the quality control indicators were set between 60 and 80. The image with the highest quality was selected for the elasticity score. The elastosonography images were color-coded to represent the elastic strain of the tissues. From soft to hard, the hardness was coded as purple, blue, green, yellow and red. Green represented the average hardness of tissue elasticity in the ultrasound sampling frame. Red and yellow indicated that the hardness was greater than the average hardness; purple and blue indicated that the hardness was less than the average hardness. VTQ inspection was performed following elastosonography. If the lesion was larger than the sampling frame, the sampling frame was placed in the center of the lesion. If the lesion was smaller than the sampling frame, the lesions were located in the center of sampling frame. The VTQ function was started, following which the machine automatically gave the measured VTQ speed values by the ROI. Each lesion was measured five times and the mean value was selected.

Diagnostic criteria

The conventional ultrasound diagnostic criteria for malignant lesions comprised an irregular shape and burr-like edge, internal microcalcifications, rear attenuation, internal rich blood flow and a resistive index (RI) >0.75. The diagnostic criteria for benign lesions included clear boundaries, insufficient blood flow and an RI ≤0.75.

The flexible ultrasound diagnostic criteria were based on the literature (7,8), whereby the elasticity image was scored according to the different colors in the lesions, as follows: 1 point, purple, green and red; 2 points, the lesion and surrounding tissue were green; 3 points, red, green and yellow lesions, with >50% green; 4 points, red, yellow and white lesions, with 50–90% red; 5 points, >90% of the lesion area was red. Elastosonography scores of 1–3 points were diagnosed as benign lesions and 4–5 points as malignant lesions.

The pathological findings were utilized as the gold standard. The sensitivity was taken as the vertical axis and one minus the specificity as the horizontal axis. The receiver operating characteristic curve was then created and the threshold was analyzed. With regard to the diagnostic criteria for the three techniques combined, lesions with at least two positive results from the three techniques were defined as malignant, the rest as benign.

Statistical analysis

Statistical Analysis System (SAS) 8.0 statistical software (SAS Institute, Inc., Cary, NC, USA) was used for the statistical analysis. The detections rates for the benign and malignant elastosonography scores and the VTQ speeds in each group were compared using a χ2 test. P<0.05 was considered to indicate a statistically significant difference. Taking pathological findings as the gold standard, the diagnostic performance using a combination of the three methods of routine ultrasound, elastosonography and VTQ technology was calculated.

Results

Pathology results

Benign breast lesions were histologically confirmed in 47 out of 86 patients; out of these 47 patients, fibroadenoma and adenosis were diagnosed in 38 and nine patients, respectively. Malignant tumors were found in 39 patients; 35 patients had invasive ductal carcinoma, one patient had invasive lobular carcinoma, two patients had medullary carcinoma and one patient had ductal carcinoma in situ.

Benign and malignant elastosonography scores

The elastosonography scores are shown in Table I. The detection rate of benign breast lesions with an elastosonography score of 1–3 points was 68.09%, which was significantly higher than that of malignant tumors (P<0.05). The benign breast lesion elastosonography scores were mainly 1–3 (Fig. 1). The detection rate of malignant tumors with an elastosonography score of 4–5 points was 82.05%, which was significantly higher than that of benign tumors (P<0.05), and the malignant breast lesion elastosonography scores were mainly 4–5 (Fig. 2). The detection rates of benign and malignant tumors with an elastosonography score of 4 points were 21.28 and 20.51%, respectively; this difference was not statistically significant (P>0.05).

Figure 1

Surgical pathology in a 31-year-old woman with a palpable mass in the inner upper quadrant of her left breast proved an adenofibroma. Left image: Two dimensional sonogram. Right image: Elastography map, 3 points.

Figure 2

Surgical pathology in a 45-year-old woman with a palpable mass in the outer upper quadrant of her right breast proved an invasive ductal carcinoma of the breast. Left image: Two dimensional sonogram. Right image: Elastography map, 5 points.

Table I

Elastography scores of benign and malignant breast lesions.

Table I

Elastography scores of benign and malignant breast lesions.

Ultrasound elastography score

1–344–5



PathologyNumber of cases (n)nDetection rate (%)nDetection rate (%)nDetection rate (%)
Benign473268.091021.281531.91
Malignant39717.95820.513282.05
VTQ speed values in benign and malignant tumors

The VTQ speed results are presented in Table II. The detection rate of benign breast tumors with a VTQ speed value of <2.98 m/sec was 74.47%, which was significantly higher than that of the malignant tumors (P<0.05); the VTQ speed of benign breast tumors was mainly <2.98 m/sec (Fig. 3). The detection rate of malignant breast tumors with a VTQ speed value of ≥2.98 m/sec was 79.49%, which was significantly higher than that of the benign tumors (P<0.05); the VTQ speed of malignant breast tumors was mainly ≥2.98 m/sec (Fig. 4).

Figure 3

Surgical pathology in a 31-year-old woman with a palpable mass in the outer upper quadrant of her right breast proved an adenofibroma. VTQ detection map (VTQ value, 2.41 m/sec). VTQ, Virtual Touch™ tissue quantification.

Figure 4

Surgical pathology in a 48-year-old woman with a palpable mass in the inner upper quadrant of her right breast proved an invasive ductal carcinoma detection map (VTQ value, 3.35 m/sec). VTQ, Virtual Touch™ tissue quantification.

Table II

VTQ speed values of benign and malignant breast lesions.

Table II

VTQ speed values of benign and malignant breast lesions.

VTQ speed value (m/sec)

V<2.98V≥2.98


PathologyNumber of cases (n)nDetection rate (%)nDetection rate (%)
Benign473574.471225.53
Malignant39820.513179.49

[i] VTQ, Virtual Touch™ tissue quantification; V, speed value.

Performance of the four types of inspection methods in the diagnosis of benign and malignant tumors

The diagnostic performance results are presented in Table III. Statistically significant differences were observed between the diagnostic accuracy of conventional ultrasound, elastosonography, VTQ technology and the three methods combined (P<0.05).

Table III

Comparison of the diagnostic performance of four types of inspection methods for benign and malignant breast lesions.

Table III

Comparison of the diagnostic performance of four types of inspection methods for benign and malignant breast lesions.

Inspection methodPreoperative diagnosisPostoperative pathologySensitivity (%)Specificity (%)Accuracy (%)

Malignant (n=39)Benign (n=47)



Malignant (n)Benign (n)Correct diagnosisMisdiagnosisCorrect diagnosisMisdiagnosis
Conventional ultrasound4145318371079.4978.7279.07
Elastosonography5036336301784.6263.8373.26
VTQ4145309361176.9276.6076.74
Combined diagnosis404636343492.3191.4991.86

[i] VTQ, Virtual Touch™ tissue quantification.

Discussion

To date, there has been a constant pursuit of the ultrasound characteristics of non-benign breast lesions, otherwise referred to as malignant tumors. Two-dimensional gray-scale ultrasound, color Doppler and pulsed Doppler techniques were gradually developed to distinguish between benign and malignant breast lesions. However, both in the two-dimensional gray-scale images and in the images obtained using color Doppler flow imaging, a large degree of overlap existed between benign and malignant lesions, rendering it difficult for conventional ultrasound make an accurate diagnosis. As a result, the emerging elastosonography and VTQ technologies were applied to the study of breast disease (9–11). Elastosonography took the biological tissue elasticity (or stiffness) and the biological characteristics of lesions as the theoretical basis, and provided a novel approach for the differential diagnosis of breast lesions. The principle underlying VTQ is that when the ROI tissues are affected by the pulse wave, shear waves accompanied by lateral transfer movement are produced; the probe pulse sequence then collects these subtle changes and the system records and calculates its speed. This speed is equivalent to or representative of tissue elasticity (12). VTQ is the absolute tissue quantitative indicator, and can not only be contrasted with neighboring tissues, but also with tissue images from different patients. VTQ compensates for the defects of the qualitative or semi-quantitative evaluation of previous elastosonography methods.

The results of this study showed that the elastosonography scores of the benign breast tumors were mainly 1–3 points, with a detection rate of 68.09%. The elastosonography scores of the malignant breast tumors were mainly 4–5 points, with a detection rate of 82.05%. The difference in the detection rate of the elastosonography score between the benign and malignant tumors was statistically significant (P<0.05). Elastosonography imaging reflected the overall hardness level of the tumor tissue compared with that of the surrounding normal breast tissue. The assessment of VTQ technology showed that the benign breast tumor VTQ speeds were mainly <2.98 m/sec, with a detection rate of 74.47%. The VTQ values of the malignant breast tumors were mainly ≥2.98 m/sec, with a detection rate of 79.49%. With regard to the VTQ speed values, the detection rates of the benign and malignant breast tumors showed a significant difference (P<0.05). The VTQ speed values increased in parallel with increasing tissue hardness. These findings may be explained by the fact that, in most cases, the benign lesions had a soft texture whereas the malignant lesions had a hard texture. The elastosonography scores were closely associated with the pathological changes, but mainly reflected the elasticity characteristics of the lesions. In 1998, Krouskop et al (13) described the elasticity of different breast tissues in decreasing order: Invasive ductal carcinoma, non-invasive ductal carcinoma, breast fibrous tissue, normal breast tissue and adipose tissue. It was speculated that the larger the tissue elasticity coefficient, the greater the hardness. The study by Konofagou (14) showed that the malignant lesions had more complex and irregular boundaries, therefore exhibiting poor mobility, reduced relative strain and a large elasticity coefficient.

The results of this present study showed that the benign and malignant tumors had a certain overlap in hardness. Although in most cases, the malignant breast tumors had a harder texture than the benign tumors, this was not absolute. In certain histological types, including medullary carcinoma of the breast, the pathology findings showed that the internal medullary carcinoma tumor cells were in a follicular arrangement and contained a lower fiber composition (15), therefore leading to a relatively soft texture. In this study, two cases of medullary carcinoma had elastosonography scores of 2 and 3 points, and the VTQ velocity values were 2.06 and 2.23 m/sec, indicating the soft texture of medullary carcinoma. Certain fibroadenomas with high degrees of fibrosis exhibited a relatively high hardness. At the same time, a variety of pathological changes within the breast lesions may also have an impact on the hardness of the lesions. The hardness may increase in benign lesions when fibrosis or calcification occur and the hardness may decrease in malignant lesions when necrosis or hemorrhage occur.

This study showed that the sensitivity, specificity and accuracy of elastosonography in the diagnosis of breast lesions were 84.62, 63.83 and 73.26%, respectively. The sensitivity, specificity and accuracy of VTQ technology in breast lesions were 76.92, 76.60 and 76.74%, respectively. When elastosonography and VTQ technology are used separately, they can only provide information regarding lesions and tissue elasticity. The hardness of benign and malignant tumors may overlap which would result in misdiagnosis. In this study, the combined diagnosis using three types of technology significantly improved the diagnostic accuracy to ≤91.86%.

In conclusion, elastosonographies of breast lesions and VTQ technology can indirectly and directly, respectively, reflect the hardness of breast lesions. This can contribute to the identification of benign and malignant tumors. However, due to the overlap in the hardness of benign and malignant tumors, actual clinical application would benefit from combining these methods with conventional ultrasound to optimize the accuracy of breast tumor diagnoses.

Acknowledgements

This study was supported by the Shanghai Pudong New Area Leading Talents Training Plan (no. PWR12012-02), the Shanghai Health Bureau Research Projects (no. 20114Y165), the Pudong New Area Health Bureau of Health Science and Technology Development (no. PW2011A-15) and the Pudong New Area Health System Training Program for Outstanding Young Medical Personnel (no. PWRq2010-09).

References

1 

Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, Yamakawa M and Matsumura T: Breast disease: clinical application of US elastography for diagnosis. Radiology. 239:341–350. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Zhi H, Xiao XY, Yang HY, Ou B, Wen YL and Luo BM: Ultrasonic elastography in breast cancer diagnosis: strain ratio vs 5-point scale. Acad Radiol. 17:1227–1233. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Nightingale KR, Palmeri ML, Nightingale RW and Trahey GE: On the feasibility of remote palpation using acoustic radiation force. J Acoust Soc Am. 110:625–634. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Nightingale K, Soo MS, Nightingale R and Trahey G: Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol. 28:227–235. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Zhai L, Palmeri ML, Bouchard RR, Nightingale RW and Nightingale KR: An integrated indenter-ARFI imaging system for tissue stiffness quantification. Ultrason Imaging. 30:95–111. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Cho SH, Lee JY, Han JK and Choi BI: Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol. 36:202–208. 2010.PubMed/NCBI

Song Y and Xia DZ: Ultrasound elastography in observation of breast tissues for normal adult females. Zhong Guo Yi Xue Ying Xiang Ji Shu. 28:1831–1834. 2012.(In Chinese).

7 

Lin T, Lin HH, Wang JH and Xu YB: Analysis of ultrasonic elastography in the diagnosis of benign and malignant lesions of breast. Zhong Guo Lin Chuang Yi Xue Ying Xiang Za Zhi. 21:797–799. 2010.(In Chinese).

8 

Luo BM, Yang HY, Xiao XY, Zhi H and Wen YL: Prospective study of improved elasticity scores in the differential diagnosis of malignant and benign breast lesions. Zhong Hua Chao Sheng Ying Xiang Xue Za Zhi. 18:514–516. 2009.(In Chinese).

9 

Thomas A, Fischer T, Frey H, Ohlinger R, Grunwald S, Blohmer JU, Winzer KJ, Weber S, Kristiansen G, Ebert B and Kümmel S: Real-time elastography - an advanced method of ultrasound: First results in 108 patients with breast lesions. Ultrasound Obstet Gynecol. 28:335–340. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Wu XP, Song QH and Du DL: Two-dimensional ultrasound, Doppler ultrasonography and ultrasonic elastography in differential diagnosis of malignant and benign breast tumors. Zhong Guo Yi Xue Ying Xiang Ji Shu. 27:971–974. 2011.(In Chinese).

11 

Shen JH, Luo BM, Ou B and Yang HY: Comparative study of ultrasonic elastography and conventional ultrasonography in differential diagnosis of breast lesions. Zhong Guo Yi Xue Ying Xiang Ji Shu. 23:540–542. 2007.(In Chinese).

12 

Shen W, Ding H, Wang WP, Li C, Xu C and Xu ZZ: Feasibility of virtual touch tissues quantification technique in the assessment of liver fibrosis. Zhong Hua Chao Sheng Ying Xiang Xue Za Zhi. 19:397–399. 2010.(In Chinese).

13 

Krouskop TA, Wheeler TM, Kallel F, Garra BS and Hall T: Elastic moduli of breast and prostate tissues under compression. Ultrason Imaging. 20:260–274. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Konofagou EE: Quo vadis elasticity imaging? Ultrasonics. 42:331–336. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Xu LZ: Breast Pathology. Shanghai Yi Ke Da Xue Chu Ban She; Shanghai: pp. 1541999

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiang Q, Zhang Y, Chen J, Zhang YX and He Z: Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors. Exp Ther Med 8: 1059-1064, 2014.
APA
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., & He, Z. (2014). Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors. Experimental and Therapeutic Medicine, 8, 1059-1064. https://doi.org/10.3892/etm.2014.1875
MLA
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., He, Z."Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors". Experimental and Therapeutic Medicine 8.4 (2014): 1059-1064.
Chicago
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., He, Z."Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors". Experimental and Therapeutic Medicine 8, no. 4 (2014): 1059-1064. https://doi.org/10.3892/etm.2014.1875
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang Q, Zhang Y, Chen J, Zhang YX and He Z: Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors. Exp Ther Med 8: 1059-1064, 2014.
APA
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., & He, Z. (2014). Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors. Experimental and Therapeutic Medicine, 8, 1059-1064. https://doi.org/10.3892/etm.2014.1875
MLA
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., He, Z."Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors". Experimental and Therapeutic Medicine 8.4 (2014): 1059-1064.
Chicago
Jiang, Q., Zhang, Y., Chen, J., Zhang, Y., He, Z."Technical evaluation of Virtual Touch™ tissue quantification and elastography in benign and malignant breast tumors". Experimental and Therapeutic Medicine 8, no. 4 (2014): 1059-1064. https://doi.org/10.3892/etm.2014.1875
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team